SearchGPT has the potential to fundamentally change how people seek and discover information. For pharma companies, failing ...

A new biotech start-up – Ouro Medicines – launched today with $120 million in funding from a Series A and a plan to develop ...

Several Mozambican companies are concerned about the circulation of fake documents after looting on 25 December during ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and ...

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated ...

Ouro is planning to leverage T cell engagers to deplete B cells and “reset” the immune system to treat immune-mediated ...

T cell engagers are having a moment, much like antibody-drug conjugates have for the past two years. The cell-depleting ...

Armed with $115 million and a clinical-stage asset, another player is emerging in the increasingly crowded T cell engager ...

Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...

There seems to be no sign of slowdown for the meme coins, however, as the cryptocurrency market heads into 2025. Previously ...

Barclays PLC lifted its stake in shares of Ambev S.A. (NYSE:ABEV – Free Report) by 76.9% in the third quarter, Holdings Channel reports. The firm owned 52,625 shares of the company’s stock after ...

As Bitcoin is firmly in control of the crypto market, smart investors are looking beyond BTC for high-yield options. The … ...